Total Funding
62
16
Total FundingSeries B raised
Growth Score
-1 pts
Heat Score
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
373782
GnuBIO is a developer of scalable DNA sequencing technology for the diagnostic and applied markets.
Acquired by 
Bio-Rad Laboratories
Tal Raz: VP, Molecular BiologyPast Role: Helicos BioSciences, Senior Scientist
About the Company
GnuBIO is a developer of scalable DNA sequencing technology for both the Diagnostic and Applied markets. The GnuBIO technology is an emulsion-based microfluidic technology, which provides a scalable desktop sequencing system that allows interrogation of single genes, gene panels, and whole genomes. Using a proprietary DNA sequencing system, the
GnuBIO’s platform encompasses all the steps required for DNA sequencing into a single platform including target selection and enrichment, DNA amplification, DNA sequencing and analysis. GnuBIO’s cutting-edge platform provides a single user interface, and a single step process, which rapidly produces results to hours versus days.
